RetractedArticleProceedings of the National Academy of Sciences of the United States of America2008

The antibody zalutumumab inhibits epidermal growth factor receptor signaling by limiting intra- and intermolecular flexibility.

Jeroen J Lammerts van Bueren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.